The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...

FRONTLINE Editor-in-Chief and Executive Producer Raney Aronson-Rath sits down with journalists and filmmakers for probing conversations about the investigative journalism that drives each FRONTLINE ...

LITTLE was known about Steven Avery outside of the US before 2015. He had been sentenced for the murder of freelance ...

Merz said the document was shared with Trump after he spoke by phone with several European leaders on Wednesday.